Summary Stage 2018: Corpus Carcinoma and Carcinosarcoma
Summary Stage 2018
Notes
**Corpus Carcinoma and Carcinosarcoma**
8000-8700, 8720-8790, 8950, 8980, 9700-9701
C540-C543, C548-C549, C559
C540 Isthmus uteri
C541 Endometrium
C542 Myometrium
C543 Fundus uteri
C548 Overlapping lesion of corpus uteri
C549 Corpus uteri
C559 Uterus, NOS
**Note 1:** The following sources were used in the development of this chapter
* SEER Extent of Disease 1988: Codes and Coding Instructions (3rd Edition, 1998) (https://seer.cancer.gov/archive/manuals/EOD10Dig.3rd.pdf)
* SEER Summary Staging Manual-2000: Codes and Coding Instructions (https://seer.cancer.gov/tools/ssm/ssm2000/)
* Collaborative Stage Data Collection System, version 02.05: https://cancerstaging.org/cstage/Pages/default.aspx
* Chapter 53 *Corpus Uteri-Carcinoma and Carcinosarcoma*, in the AJCC Cancer Staging Manual, Eighth Edition (2017) published by Springer International Publishing. Used with permission of the American College of Surgeons, Chicago, Illinois.
**Note 2:** See the following schemas for the listed histologies
* 8710-8714, 8800-8941, 8951-8975, 8981-9137, 9141-9582: *Corpus Sarcoma*
* 9140: *Kaposi Sarcoma*
SS2018 |
Description |
0 |
In situ, intraepithelial, noninvasive, preinvasive |
1 |
Localized only (localized, NOS)
- FIGO Stage IA
+ Invasion of inner half of myometrium
- FIGO Stage IB
+ Invasion of outer half of myometrium
- FIGO Stage I [NOS]
+ Confined to uterus, NOS
+ Invasion of myometrium, NOS
+ Invasive cancer confined to corpus uteri |
2 |
Regional by direct extension only
- FIGO Stage II
+ Cervix uteri, NOS
+ Cervical stromal invasion
+ Endocervical glandular involvement
+ Tumor invading the stromal connective tissue of the cervix but not extending beyond the uterus
- FIGO Stage IIIA
+ Adnexa (direct extension or metastasis)
+ Fallopian tube(s)
+ Ovary(ies)
+ Serosa, NOS
+ Tunica serosa (visceral peritoneum of corpus, serosa covering the corpus)
+ Tunica serosa of corpus
- FIGO Stage IIIB
+ Bladder, NOS (excluding mucosa)
+ Described clinically as "frozen pelvis", NOS
+ Ligaments (broad, round, uterosacral)
+ Parametrium, NOS
+ Parietal serosa of pelvic wall
+ Pelvic wall(s)
+ Peritoneal cytology positive for malignant cells
+ Rectal wall
+ Rectum, NOS excluding mucosa
+ Ureter
+ Vagina (direct extension or metastasis)
+ Visceral peritoneum of pelvic organs excluding serosa of corpus
+ Vulva
- FIGO Stage III [NOS] |
3 |
Regional lymph node(s) involved only
- Aortic (lateral [lumbar], Periaortic, NOS)
- Iliac (external, internal [hypogastric], NOS)
- Lateral (laterosacral)
- Middle (promontorial) (Gerota’s node)
- Obturator
- Para-aortic
- Paracervical
- Parametrial
- Pelvic, NOS
- Presacral
- Sacral
- Uterosacral
- Regional lymph node(s), NOS
+ Lymph node(s), NOS |
4 |
Regional by BOTH direct extension AND regional lymph node(s) involved
- Codes (2) + (3) |
7 |
Distant site(s)/lymph node(s) involved
- Distant site(s) (including further contiguous extension)
+ FIGO Stage IVA
* Abdominal serosa (visceral or parietal peritoneum of abdomen)
* Bladder mucosa (excluding bullous edema)
* Bowel mucosa
* Cul de sac (rectouterine pouch or Pouch of Douglas)
* Sigmoid colon
* Small intestine
+ FIGO Stage IVB
* Bone
* Intraperitoneal disease
* Liver
* Lung
+ FIGO Stage IV [NOS]
- Distant lymph node(s), NOS
+ Deep inguinal, NOS
* Node of Cloquet or Rosenmuller (highest deep inguinal)
+ Inguinal, NOS
+ Superficial inguinal (femoral)
- Distant metastasis, NOS
+ Carcinomatosis
+ Distant metastasis WITH or WITHOUT distant lymph node(s) |
9 |
Unknown if extension or metastasis |
(1) Fritz AG, Ries LAG (eds). **SEER Extent of Disease 1988: Codes and Coding Instructions (3rd Edition, 1998)**, National Cancer Institute, NIH Pub. No. 98-2313, Bethesda, MD, 1998
(2) Young JL Jr, Roffers SD, Ries LAG, Fritz AG, Hurlbut AA (eds.). **SEER Summary Staging Manual-2000: Codes and Coding Instructions**, National Cancer Institute, NIH Pub. No. 01-4969, Bethesda, MD, 2001.
(3) Collaborative Stage Work Group of the American Joint Committee on Cancer. **Collaborative Stage Data Collection System User Documentation and Coding Instructions, version 02.05.** American Joint Committee on Cancer (Chicago, IL)
(4) Gress, D.M., Edge, S.B., Gershenwald, J.E., et al. **Principles of Cancer Staging.** In: Amin, M.B., Edge, S.B., Greene, F.L., et al. (Eds.) AJCC Cancer Staging Manual. 8th Ed. New York: Springer; 2017: 3-30
(5) **Introduction to Female Reproductive Organs**. In: Amin, M.B., Edge, S.B., Greene, F.L., et al. (Eds.) AJCC Cancer Staging Manual. 8th Ed. New York: Springer; 2017: 631
(6) Powell, M.A., Olawaiye, A.B., Mutch, D.G., et al. **Corpus Uteri – Carcinoma and Carcinosarcoma**. In: Amin, M.B., Edge, S.B., Greene, F.L., et al. (Eds.) AJCC Cancer Staging Manual. 8th Ed. New York: Springer; 2017: 661-669